Radiomics with artificial intelligence for precision medicine in radiation therapy

Hidetaka Arimura, Mazen Soufi, Hidemi Kamezawa, Kenta Ninomiya, Masahiro Yamada

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Recently, the concept of radiomics has emerged from radiation oncology. It is a novel approach for solving the issues of precision medicine and how it can be performed, based on multimodality medical images that are noninvasive, fast and low in cost. Radiomics is the comprehensive analysis of massive numbers of medical images in order to extract a large number of phenotypic features (radiomic biomarkers) reflecting cancer traits, and it explores the associations between the features and patients' prognoses in order to improve decision-making in precision medicine. Individual patients can be stratified into subtypes based on radiomic biomarkers that contain information about cancer traits that determine the patient's prognosis. Machine-learning algorithms of AI are boosting the powers of radiomics for prediction of prognoses or factors associated with treatment strategies, such as survival time, recurrence, adverse events, and subtypes. Therefore, radiomic approaches, in combination with AI, may potentially enable practical use of precision medicine in radiation therapy by predicting outcomes and toxicity for individual patients.

Original languageEnglish
Pages (from-to)150-157
Number of pages8
JournalJournal of radiation research
Volume60
Issue number1
DOIs
Publication statusPublished - Jan 1 2019

Fingerprint

artificial intelligence
Precision Medicine
Artificial Intelligence
medicine
prognosis
radiation therapy
Radiotherapy
biomarkers
cancer
machine learning
Radiation Oncology
decision making
Tumor Biomarkers
toxicity
Decision Making
Biomarkers
costs
Costs and Cost Analysis
Recurrence
Survival

All Science Journal Classification (ASJC) codes

  • Radiation
  • Radiology Nuclear Medicine and imaging
  • Health, Toxicology and Mutagenesis

Cite this

Radiomics with artificial intelligence for precision medicine in radiation therapy. / Arimura, Hidetaka; Soufi, Mazen; Kamezawa, Hidemi; Ninomiya, Kenta; Yamada, Masahiro.

In: Journal of radiation research, Vol. 60, No. 1, 01.01.2019, p. 150-157.

Research output: Contribution to journalArticle

Arimura, Hidetaka ; Soufi, Mazen ; Kamezawa, Hidemi ; Ninomiya, Kenta ; Yamada, Masahiro. / Radiomics with artificial intelligence for precision medicine in radiation therapy. In: Journal of radiation research. 2019 ; Vol. 60, No. 1. pp. 150-157.
@article{7aaa42644c4040ed9a5387023222ecd3,
title = "Radiomics with artificial intelligence for precision medicine in radiation therapy",
abstract = "Recently, the concept of radiomics has emerged from radiation oncology. It is a novel approach for solving the issues of precision medicine and how it can be performed, based on multimodality medical images that are noninvasive, fast and low in cost. Radiomics is the comprehensive analysis of massive numbers of medical images in order to extract a large number of phenotypic features (radiomic biomarkers) reflecting cancer traits, and it explores the associations between the features and patients' prognoses in order to improve decision-making in precision medicine. Individual patients can be stratified into subtypes based on radiomic biomarkers that contain information about cancer traits that determine the patient's prognosis. Machine-learning algorithms of AI are boosting the powers of radiomics for prediction of prognoses or factors associated with treatment strategies, such as survival time, recurrence, adverse events, and subtypes. Therefore, radiomic approaches, in combination with AI, may potentially enable practical use of precision medicine in radiation therapy by predicting outcomes and toxicity for individual patients.",
author = "Hidetaka Arimura and Mazen Soufi and Hidemi Kamezawa and Kenta Ninomiya and Masahiro Yamada",
year = "2019",
month = "1",
day = "1",
doi = "10.1093/jrr/rry077",
language = "English",
volume = "60",
pages = "150--157",
journal = "Journal of Radiation Research",
issn = "0449-3060",
publisher = "Japan Radiation Research Society",
number = "1",

}

TY - JOUR

T1 - Radiomics with artificial intelligence for precision medicine in radiation therapy

AU - Arimura, Hidetaka

AU - Soufi, Mazen

AU - Kamezawa, Hidemi

AU - Ninomiya, Kenta

AU - Yamada, Masahiro

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Recently, the concept of radiomics has emerged from radiation oncology. It is a novel approach for solving the issues of precision medicine and how it can be performed, based on multimodality medical images that are noninvasive, fast and low in cost. Radiomics is the comprehensive analysis of massive numbers of medical images in order to extract a large number of phenotypic features (radiomic biomarkers) reflecting cancer traits, and it explores the associations between the features and patients' prognoses in order to improve decision-making in precision medicine. Individual patients can be stratified into subtypes based on radiomic biomarkers that contain information about cancer traits that determine the patient's prognosis. Machine-learning algorithms of AI are boosting the powers of radiomics for prediction of prognoses or factors associated with treatment strategies, such as survival time, recurrence, adverse events, and subtypes. Therefore, radiomic approaches, in combination with AI, may potentially enable practical use of precision medicine in radiation therapy by predicting outcomes and toxicity for individual patients.

AB - Recently, the concept of radiomics has emerged from radiation oncology. It is a novel approach for solving the issues of precision medicine and how it can be performed, based on multimodality medical images that are noninvasive, fast and low in cost. Radiomics is the comprehensive analysis of massive numbers of medical images in order to extract a large number of phenotypic features (radiomic biomarkers) reflecting cancer traits, and it explores the associations between the features and patients' prognoses in order to improve decision-making in precision medicine. Individual patients can be stratified into subtypes based on radiomic biomarkers that contain information about cancer traits that determine the patient's prognosis. Machine-learning algorithms of AI are boosting the powers of radiomics for prediction of prognoses or factors associated with treatment strategies, such as survival time, recurrence, adverse events, and subtypes. Therefore, radiomic approaches, in combination with AI, may potentially enable practical use of precision medicine in radiation therapy by predicting outcomes and toxicity for individual patients.

UR - http://www.scopus.com/inward/record.url?scp=85061582885&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85061582885&partnerID=8YFLogxK

U2 - 10.1093/jrr/rry077

DO - 10.1093/jrr/rry077

M3 - Article

VL - 60

SP - 150

EP - 157

JO - Journal of Radiation Research

JF - Journal of Radiation Research

SN - 0449-3060

IS - 1

ER -